SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish BMF short report, released amid options expiration and broader biotech weakness, is being cited as the immediate driver of SELLASs sharp decline despite no adverse company announcement. Traders are divided between dismissing the report as an unverified short-side thesis and worrying that delays around the 80th REGAL event or the pending Phase 3 readout could indicate clinical risk.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is drawing sympathy interest after Moderna and Merck reported a positive late-stage personalized cancer-vaccine result, prompting speculation that Novavaxs Matrix-M adjuvant could benefit from the broader oncology-vaccine momentum. Traders are divided between a potential Matrix-M licensing catalyst and short-squeeze setup, and skeptics who view the move as unsupported without a Novavax-specific deal or clinical update.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

A sharp sector-wide AI/neocloud selloff, amplified by reports that Nvidia paused or changed a GPU financing program, is driving attention; traders note that BRUN was not directly implicated and that Nvidia denied the report. Debate also centers on warrant-redemption dilution and potential capital raises versus confidence in BRUNs Q2 growth, contracted demand, and Nvidia partnership.

Reading International, Inc. is an entertainment and real estate company, which engages in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through the Cinema Exhibition and Real Estate segments. The Cinema Exhibition segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, City Cinemas, 44 Union Square, and Liberty Theatres brands. The Real Estate segment consists of real estate development and the rental or licensing of retail, commercial and live theater assets. The company was founded by James J. Cotter Sr. in 1999 and is headquartered in New York, NY.

Reading International Inc - Ordinary Shares - Class B

A sharp move in RDIB is drawing attention as traders focus on its very small public float, limited liquidity and potential short squeeze. Bullish participants cite recent strong financial results and takeover speculation, while others view the move as a low-float momentum trade and warn of volatility, halts and selling pressure.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

A sharp silver selloff has been attributed by traders to Kevin Warshs hawkish Jackson Hole messaging, with rising yields and a firmer dollar weighing on precious metals. The community remains divided between near-term caution around support and profit-taking and longer-term bullish views tied to Treasury bond buybacks, debt concerns, inflation, and currency debasement.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

A sharp, sympathy-driven selloff across AI and data-center stocksparticularly following traders reaction to IRENs weak earnings and broader rate-driven pressureis driving attention, alongside concerns about short selling and thin volume. Bulls argue Applied Digitals strong recent earnings, contracted backlog and upcoming data-center milestones make the decline disconnected from fundamentals, while bears cite the persistent downtrend, cash-flow risks and management silence.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists rally is centered on its Samsung licensing settlement and the expectation that it strengthens the companys position in ongoing patent disputes, particularly with Micron, alongside scheduled Federal Circuit arguments on September 9. Traders are broadly bullish and anticipate additional Micron or SK hynix agreements, although those outcomes remain speculative and the community continues to debate the status of related ITC cases.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Hawkish Federal Reserve commentary around the Jackson Hole symposium and rising rate-hike expectations are driving attention, with traders linking the selloff to macro pressure on fintech and bank-sensitive stocks. The community is split between bears expecting further weakness and bulls arguing that potential hikes are already reflected in SoFis guidance and viewing the dip as a buying opportunity, while options-related selling and resistance near recent levels add volatility.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Questions around whether Auvelitys Alzheimers agitation launch is translating into accelerating prescription growth are driving attention, with traders closely watching upcoming prescription updates and earnings. The community is split between bullish investors citing strong underlying demand and possible undercounting of institutional prescriptions, and skeptics concerned that flat or slowing weekly scripts and low-volume selling signal a slower-than-expected rollout.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trumps move to rename Lake Ontario Lake America is driving the dominant conversation, with traders debating it as a symbolic political win versus an embarrassing distraction amid tensions with Canada, tariffs, war, and inflation. The discussion is broadly bearish on DJT, also citing the companys weak business performance and its close association with Trumps political controversies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned

FDA rejects Achieve Life Sciences application for cytisinicline tied to manufacturing issues, with NDA resubmission planned in Q4 2026.read more...

Achieve Life Sciences Reports Q1 2026 Results: Full Earnings Call Transcript

Achieve Life Sciences (ACHV) to Release Quarterly Earnings on Tuesday

Achieve Life Sciences (NASDAQ:ACHV) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-achieve-life-sciences-inc-stock...

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving Average   - Time to Sell?

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Rating of "Buy" by Brokerages

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been assigned an average recommendation of "Buy" from the six ratings firms that are presently covering the firm, Marketbeat reports...

ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally?

Equity

Though Achieve Life Sciences expects the FDA to reject its current cytisinicline application for the treatment of nicotine dependence, the company is hopeful of imminent approval following a resubmission in the fourth quarter. 


Achieve Life Sciences' (ACHV) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $12.00 target price on shares of Achieve Life Sciences in a research report on Thursday...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five analysts that are presently covering the firm...

What is Zacks Research's Estimate for ACHV FY2026 Earnings?

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Zacks Research dropped their FY2026 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on...

HC Wainwright Has Positive Estimate for ACHV FY2026 Earnings

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Equities researchers at HC Wainwright boosted their FY2026 earnings estimates for shares of Achieve Life Sciences in a research report issued...

• Reported GAAP EPS of -$0.80 down -116.22% YoY
• Achieve Life Sciences anticipates potential FDA approval for cytisinicline in the first half of 2027, which will be followed by a U.S. commercial launch of the treatment for nicotine dependence.

Achieve Life Sciences faces regulatory delays following an FDA Complete Response Letter, alongside a significant quarterly net loss and a transition to a stockholders' equity deficit during the period.

Achieve Life Sciences secured substantial new financing to support clinical trials and commercialization while strengthening its leadership team and confirming that the FDA raised no safety or efficacy concerns.

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Achieve Life Sciences Inc.

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACHV Achieve Life Sciences Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest ACHV News